Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $539 Billion
  • Q1 2025

Adar1 Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $539 Billion distributed in 202 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $45.4B, Ea Series Trust with a value of $37.6B, Roivant Sciences Ltd. with a value of $35.1B, Zai Lab LTD with a value of $34B, and Immunovant, Inc. with a value of $16.6B.

Examining the 13F form we can see an increase of $38.3B in the current position value, from $500B to 539B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $539 Billion
Healthcare: $348 Billion
ETFs: $21.5 Billion
Consumer Cyclical: $293 Million
Utilities: $103 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$693M
$2.41 Billion 0.45% of portfolio
490,743
Q1 2025 Added 1,481.26%
Bridgebio Pharma Inc
-
$2.28 Billion 0.42% of portfolio
-
Q4 2024 New
$1.36B
$2.2 Billion 0.41% of portfolio
170,000
Q1 2025 New
$419M
$2.2 Billion 0.41% of portfolio
313,354
Q1 2025 New
A Spac Iii Acquisition Corp
-
$2.16 Billion 0.4% of portfolio
-
Q1 2025 New
$3.66B
$1.95 Billion 0.36% of portfolio
36,890
Q1 2025 Added 19.23%
$106M
$1.9 Billion 0.35% of portfolio
149,385
Q4 2024 Added 381.08%
$1.77B
$1.78 Billion 0.33% of portfolio
53,125
Q4 2024 Reduced 39.92%
Kala Bio Inc
-
$1.71 Billion 0.32% of portfolio
-
Q1 2025 Added 35.66%
$730M
$1.62 Billion 0.3% of portfolio
250,000
Q1 2025 Added 290.22%
$231M
$1.61 Billion 0.3% of portfolio
241,800
Q1 2025 Added 14.38%
$117M
$1.48 Billion 0.28% of portfolio
1,066,309
Q1 2025 Added 500.04%
$2.23B
$1.43 Billion 0.27% of portfolio
59,413
Q1 2025 Added 538.85%
$373M
$1.41 Billion 0.26% of portfolio
490,532
Q1 2025 Added 149.96%
Cargo Therapeutics Inc
-
$1.39 Billion 0.26% of portfolio
-
Q1 2025 New
Soleno Therapeutics Inc
-
$1.35 Billion 0.25% of portfolio
-
Q1 2025 Reduced 48.87%
$5.49B
$1.27 Billion 0.24% of portfolio
20,000
Q1 2025 Reduced 31.27%
$248M
$1.22 Billion 0.23% of portfolio
211,579
Q1 2025 Reduced 67.35%
Checkpoint Therapeutics Inc
-
$1.24 Billion 0.23% of portfolio
-
Q1 2025 New
Korro Bio Inc
-
$1.2 Billion 0.22% of portfolio
-
Q1 2025 Added 18.52%
Contineum Therapeutics Inc
-
$1.18 Billion 0.22% of portfolio
-
Q1 2025 Added 105.23%
Tectonic Therapeutic Inc
-
$1.11 Billion 0.21% of portfolio
-
Q1 2025 Added 6.63%
Vistagen Therapeutics Inc
-
$1.05 Billion 0.2% of portfolio
-
Q1 2025 Added 246.42%
$637M
$1.06 Billion 0.2% of portfolio
79,000
Q1 2025 Added 203.85%
$142B
$1.04 Billion 0.19% of portfolio
41,050
Q1 2025 Added 17.12%
Ares Acquisition Corp Ii
-
$1.01 Billion 0.19% of portfolio
-
Q1 2025 Reduced 34.9%
$2.02B
$950 Million 0.18% of portfolio
40,000
Q1 2025 New
Kiniksa Pharmaceuticals Intl
-
$920 Million 0.17% of portfolio
-
Q1 2025 Reduced 75.11%
$2.94B
$916 Million 0.17% of portfolio
13,962
Q1 2025 Added 252.4%
$61.2B
$863 Million 0.16% of portfolio
1,361
Q4 2024 Added 56.26%
Keen Vision Acquisition Corp
-
$842 Million 0.16% of portfolio
-
Q4 2023 New
Grace Therapeutics Inc
-
$783 Million 0.15% of portfolio
-
Q1 2025 Reduced 55.6%
$2.15B
$817 Million 0.15% of portfolio
27,900
Q1 2025 New
Kezar Life Sciences Inc
-
$719 Million 0.13% of portfolio
-
Q4 2024 Reduced 88.99%
$1.97B
$717 Million 0.13% of portfolio
56,300
Q1 2025 Added 336.43%
Zymeworks Inc
-
$596 Million 0.11% of portfolio
-
Q1 2025 New
$358M
$604 Million 0.11% of portfolio
101,096
Q1 2025 Reduced 23.18%
Structure Therapeutics Inc
-
$617 Million 0.11% of portfolio
-
Q1 2025 Added 0.85%
$103M
$577 Million 0.11% of portfolio
801,277
Q4 2024 Added 7.78%
$15.3B
$601 Million 0.11% of portfolio
4,250
Q1 2025 New
Lexeo Therapeutics Inc
-
$591 Million 0.11% of portfolio
-
Q1 2025 Added 0.56%
Kiora Pharmaceuticals Inc
-
$586 Million 0.11% of portfolio
-
Q1 2025 Reduced 2.77%
$19.2B
$616 Million 0.11% of portfolio
4,500
Q1 2025 Added 47.78%
$34.1M
$523 Million 0.1% of portfolio
122,690
Q4 2024 New
Biohaven LTD
-
$544 Million 0.1% of portfolio
-
Q1 2025 New
$0
$503 Million 0.09% of portfolio
10,000
Q3 2024 Reduced 81.13%
$760B
$496 Million 0.09% of portfolio
600
Q1 2025 Reduced 55.56%
$11.8M
$475 Million 0.09% of portfolio
479,883
Q1 2025 Added 143.29%
$5.47B
$494 Million 0.09% of portfolio
1,490
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 202
  • Current Value $539 Billion
  • Prior Value $500 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 47 stocks
  • Additional Purchases 68 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email